Search
for
Sort by
Research 631–660 of 1000+
- Maryland Community Colleges Technology Needs Assessment Survey. Final Technical Report.
- Preclinical and Clinical Efficacy of a Green Tea, Bamboo, and Selenium Supplement for the Management of Acute Telogen Effluvium in Women
- Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia
- Transgender and Gender Diverse Health Care in the US Military: What Dermatologists Need to Know
- Equine Hoof Stratum Internum K14+CD105+ Progenitor Cells: Culture, Characterization, and Model of Epithelial to Mesenchymal Transition
- Resurgent Clinical Science (and it's all about Health)
- The effect of minoxidil on human hair growth in vitro
- Comparative clinical assessment of 5% minoxidil topical application with supplemental intradermal meso-solution administration for the management of androgenetic alopecia in men
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss
- A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
- Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Therapeutic and Clinical Potential of Adipose-Derived Stem Cell Secretome for Skin Regeneration
- Enhanced Differentiation Potential of Pigmented Human Epidermal Equivalents
- Novel Vegan Exosome-like Biomimetic Vesicles for Skin and Hair Follicle Protection and Rejuvenation: Structural and Functional Characterization and Placebo-Controlled Clinical Efficacy Studies
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- stem cell translation and bioethics
- IMMUNE-DRIVEN ACTIVATION OF HAIR FOLLICLE STEM CELLS AS A TRANSLATIONAL MODEL FOR FUTURE CELL-BASED THERAPY DEVELOPMENT
- Randomized Control Clinical Trial to assess the combine effect of Bhringaraja Taila Shiroabhyanga and Yastimadhuka Taila Nasya in Khalitya of Females
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Covid-19 in Lupus Nephritis
- 1380 PPAR-γ modulation as a novel therapeutic strategy for scarring alopecia
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Characteristics of robotically harvested hair follicles in Koreans
- Formulation and clinical evaluation of niosomal methylene blue for successful treatment of acne
- Minimizing injury to the donor area in follicular unit extraction (FUE) harvesting
- Human hair follicle and interfollicular keratinocyte reactivity to mouse HPV16-transformed cells: An in vitro study